Semaglutide vs Tirzepatide: What To Ask Your Clinic
Semaglutide and tirzepatide are both injectable medications used in weight management and metabolic health contexts, but they differ in their mechanism of action, clinical evidence, and availability across different markets.
Semaglutide is a GLP-1 receptor agonist that works by mimicking the action of a single hormone involved in appetite regulation and blood sugar control. Tirzepatide is a dual agonist that targets both GLP-1 and GIP receptors, a more recent approach that has shown strong outcomes in clinical trials.
In terms of evidence, both drugs have been studied in large randomized controlled trials. Tirzepatide trials have reported higher average weight loss percentages in some studies, but these results reflect averages across trial populations and individual outcomes vary considerably based on factors including adherence, lifestyle, dosing, and underlying health status.
Availability differs by country and indication. Semaglutide was approved in the US earlier than tirzepatide, and availability through licensed clinic pathways may be more limited in some regions.
Neither drug should be chosen based on headline trial numbers alone. The right choice depends on individual health profile, medical history, contraindications, and the recommendation of a licensed clinician following proper assessment. Both require ongoing monitoring and should be used as part of a broader lifestyle program.
This guide is informational and does not constitute medical advice. Use Peptide Clinic Finder to compare clinics offering these treatments and send direct inquiries to providers with structured, supervised programs.
Source: FDA: Drugs@FDA — semaglutide approvals (OZEMPIC NDA209637, WEGOVY NDA215256) · United States · Status verified August 31, 2026
Source: FDA: Drugs@FDA — tirzepatide approvals (MOUNJARO NDA215866, ZEPBOUND NDA217806) · United States · Status verified August 31, 2026
For the US online route, our guide to compounded tirzepatide cost gives the month to month price range and median across US telehealth programs, every figure read daily from the provider's own page and dated, with brand-name Zepbound priced alongside.
Wondering what comes after tirzepatide? Our retatrutide guide covers Lilly's triple agonist: the Phase 3 results as reported, why it is not FDA approved or available, and when Lilly plans to file.
Wondering what the branded medicines cost without insurance? Our brand-name GLP-1 price chart sets Zepbound, Wegovy and Ozempic cash prices side by side across LillyDirect, NovoCare, Ro and Hims, read daily from each seller's page, and the Zepbound cost without insurance guide covers the list price, Lilly's self-pay program and the compounded route for tirzepatide alone.
Three newer weight-management medicines are still in clinical trials, none of them approved: retatrutide, the GLP-1, GIP and glucagon triple agonist; survodutide, a GLP-1 and glucagon dual agonist also studied for liver fat; and cagrilintide, the amylin analogue tested in combination with a GLP-1 medicine. Each reference page sets out the trial evidence and the approval status.
Prescribed a dose in milligrams but using a syringe marked in units? Our mg to units converter works out the syringe units from your vial's concentration. Check every dose with your prescriber or pharmacist.
Frequently asked questions
Which is better, semaglutide or tirzepatide?
Neither is universally better. The right choice depends on individual health profile, medical history, and clinician recommendation. Both require proper medical assessment before use.
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist while tirzepatide is a dual GIP and GLP-1 receptor agonist. Tirzepatide has shown higher average weight loss in some trials but individual outcomes vary.
Can I switch from semaglutide to tirzepatide?
Any change in treatment should be discussed with a licensed clinician who can assess your individual circumstances and medical history.
Next step
Compare clinics offering this treatment
Use city pages, treatment comparisons, and clinic listings together. That gives you a better view of program quality, pricing context, and oversight than reading a guide in isolation.
Continue researching
Curated pricing and clinic research
Pricing comparisons
Treatment context
For clinics
Are you a clinic?
Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.